Correlation Between Nkarta and Immunitybio

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Nkarta and Immunitybio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Nkarta and Immunitybio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Nkarta Inc and Immunitybio, you can compare the effects of market volatilities on Nkarta and Immunitybio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Nkarta with a short position of Immunitybio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Nkarta and Immunitybio.

Diversification Opportunities for Nkarta and Immunitybio

-0.71
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Nkarta and Immunitybio is -0.71. Overlapping area represents the amount of risk that can be diversified away by holding Nkarta Inc and Immunitybio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Immunitybio and Nkarta is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Nkarta Inc are associated (or correlated) with Immunitybio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Immunitybio has no effect on the direction of Nkarta i.e., Nkarta and Immunitybio go up and down completely randomly.

Pair Corralation between Nkarta and Immunitybio

Given the investment horizon of 90 days Nkarta is expected to generate 1.68 times less return on investment than Immunitybio. In addition to that, Nkarta is 1.34 times more volatile than Immunitybio. It trades about 0.02 of its total potential returns per unit of risk. Immunitybio is currently generating about 0.05 per unit of volatility. If you would invest  296.00  in Immunitybio on August 31, 2024 and sell it today you would earn a total of  208.00  from holding Immunitybio or generate 70.27% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Nkarta Inc  vs.  Immunitybio

 Performance 
       Timeline  
Nkarta Inc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Nkarta Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.
Immunitybio 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Immunitybio are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Immunitybio showed solid returns over the last few months and may actually be approaching a breakup point.

Nkarta and Immunitybio Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Nkarta and Immunitybio

The main advantage of trading using opposite Nkarta and Immunitybio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Nkarta position performs unexpectedly, Immunitybio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Immunitybio will offset losses from the drop in Immunitybio's long position.
The idea behind Nkarta Inc and Immunitybio pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.

Other Complementary Tools

CEOs Directory
Screen CEOs from public companies around the world
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing